Subscribe
marilyn-nieves
marilyn-nieves / iStockphoto.com
7 September 2017Americas

PhRMA and BIO take legal action against Nevada law

Two biotech associations have filed litigation in a district court challenging the provisions of a Nevada law, saying it violates patent rights.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More on this story

Americas
PhRMA reacts to FDA’s biosimilars guidance
15 August 2014   PhRMA has voiced concerns about the FDA’s draft guidance on biosimilars, which it suggests if enacted, could have an impact on the safety of biosimilar products.
Americas
PhRMA urges USTR to protect US innovation abroad
13 February 2017   The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.
Plant Varieties
Nevada judge overrules objections in patent disclosure suit
20 July 2021   A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York